by AIP Online Bureau | May 10, 2026 | Health, Indian News, Regulation
In an advisory issued by the Central Drugs Standard Control Organisation (CDSCO) on April 21, the regulator said it has observed instances where companies obtained approval for a new drug but launched the product in the market much later while submitting Periodic...
by AIP Online Bureau | Sep 22, 2025 | Eco/Invest/Demography, Health, Indian News, Risk Management
Additionally, the state drugs testing laboratories identified 62 samples as “not of standard quality” (NSQ) in the month under review, they said. In August, three drug samples from Bihar were identified as spurious, which were manufactured by an unauthorised...
by AIP Online Bureau | Jul 19, 2025 | Data, Eco/Invest/Demography, Health, Policy, Regulation, Risk Management
These drugs were manufactured by an unauthorized entity using a brand name owned by another company, and the matter is under investigation and action will be taken in accordance with relevant rules. New Delhi: The central drugs laboratories have found 55 samples...
by AIP Online Bureau | Dec 28, 2024 | Health, Regulation, Risk Management
Besides, 70 drug samples tested by the state drugs testing laboratories have also been identified as NSQ in November, they official sources said New Delhi: Central Drugs Standard Control Organisation (CDSCO) has found 41 drug samples tested in the central drug...
by AIP Online Bureau | Dec 17, 2024 | Health, Risk Management
The CDSCO and the Ministry of Health and Family Welfare have taken several measures to ensure that the drugs produced in the country meet the required safety and efficacy standards The number of batches of drugs recalled after failing quality tests rose from 950 in...
